Skip to main content
. 2023 Feb 23;8:23. doi: 10.1038/s41541-023-00622-0

Fig. 5. Peak and day 4 viral loads following challenge with delta SARS-CoV-2.

Fig. 5

Group 1 received three sham doses, Group 2 received three doses of GBP510-Wu, Group 3 received two doses of GBP510-Wu and one dose of GBP510-SA, and Group 4 received two doses of GBH510-Wu and one sham dose. A Subgenomic RNA (sgRNA) copies/mL in the bronchoalveolar lavage (BAL) following Delta SARS-CoV-2 challenge at peak and at Day 4 postchallenge. Median lines are shown with red bars. Vaccinated groups were compared with sham controls by two-sided Mann-Whitney tests. ***p < 0.0005, **p < 0.005, *p < 0.05. B Subgenomic RNA (sgRNA) copies/swab in the nasal swabs (NS) following Delta SARS-CoV-2 challenge at peak and at Day 4 postchallenge. Median lines are shown with red bars. Vaccinated groups were compared with sham controls by two-sided Mann-Whitney tests. ***p < 0.0005, **p < 0.005, *p < 0.05.